One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-112989
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
Affiliation: Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, The Ohio State University, Stanford University, Stanford Medicine, Gilead Sciences (United States), St James's University Hospital, Mayo Clinic, Cornell University, Janssen (United States), Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Willamette Valley Cancer Institute and Research Center, Pharmacyclics (United States), Jacksonville College, Winneshiek Medical CenterRisk Model for Overall Survival for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Validated for Patients on Ibrutinib, Idelalisib, Venetoclax, or Chemoimmunotherapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
